Recordati Industria Chimica e Farmaceutica (RCDTF) Earnings Date, Estimates & Call Transcripts $52.25 0.00 (0.00%) (As of 10/17/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest Earnings SummaryLatest Earnings DateJul. 30EstimatedActual EPS (Jul. 30) $0.70 Beat By $0.70 Get Recordati Industria Chimica e Farmaceutica Earnings AlertsEnter your email address below to receive the latest news and earnings results for RCDTF and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRCDTF Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RCDTF Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Chaikin Analytics320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shiftGet the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock RCDTF Earnings Date and InformationRecordati Industria Chimica e Farmaceutica last announced its quarterly earnings data on July 30th, 2024. The reported $0.70 EPS for the quarter. The firm earned $622 million during the quarter. Recordati Industria Chimica e Farmaceutica has generated $2.00 earnings per share over the last year ($2.00 diluted earnings per share) and currently has a price-to-earnings ratio of 26.1. Read More Recordati Industria Chimica e Farmaceutica Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks7/30/2024Q2 2024-$0.70+$0.70$0.88-$622.00 million5/9/2024Q1 2024-$0.85+$0.85$1.06-$659.94 million2/22/2024Q4 2023-$0.61+$0.61$0.78-$566.56 million11/7/2023Q3 2023-$0.62+$0.62$0.84-$557.14 million7/28/2023Q2 2023-$0.69+$0.69$0.84-$536.58 million5/11/2023Q1 2023-$0.81+$0.81$0.98-$591.52 million Get the Latest News and Ratings for RCDTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and its competitors with MarketBeat's FREE daily newsletter. 3/16/2023Q4 2022-$0.58+$0.58$0.81-$485.80 million11/8/2022Q3 2022-$0.63+$0.63$0.83-$488.89 million7/28/2022Q2 2022-$0.56+$0.56$0.84-$504.07 million5/10/2022Q1 2022-$0.64+$0.64$0.75-$470.63 million3/17/2022Q4 2021-$0.62+$0.62$0.74-$484.79 million10/28/2021Q3 2021-$0.59+$0.59$0.67-$454.41 million7/29/2021Q2 2021-$0.60+$0.60$0.53-$465.09 million5/6/2021Q1 2021-$0.61+$0.61$0.70-$463.90 million3/18/2021Q4 2020-$0.53+$0.53$0.60-$423.46 million10/29/2020Q3 2020-$0.51+$0.51$0.59-$389.95 million7/30/2020Q2 2020-$0.53+$0.53$0.61-$364.42 million5/7/2020Q1 2020-$0.66+$0.66$0.73-$473.47 million3/18/2020Q4 2019-$0.61+$0.61$0.61-$422.47 million10/31/2019Q3 2019-$0.42+$0.42$0.42-$397.17 million Recordati Industria Chimica e Farmaceutica Earnings - Frequently Asked Questions When did Recordati Industria Chimica e Farmaceutica announce their last quarterly earnings? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) last announced its quarterly earning data on Tuesday, July 30, 2024. Learn more on RCDTF's earnings history. How much revenue does Recordati Industria Chimica e Farmaceutica generate each year? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a recorded annual revenue of $2.25 billion. How much profit does Recordati Industria Chimica e Farmaceutica generate each year? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a recorded net income of $421.25 million. RCDTF has generated $2.00 earnings per share over the last four quarters. What is Recordati Industria Chimica e Farmaceutica's price-to-earnings ratio? Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) has a trailing price-to-earnings ratio of 26.13. More Earnings Resources from MarketBeat Related Companies: OLCLY Earnings SVNDY Earnings CHCJY Earnings ASHTY Earnings KHNGY Earnings SMCAY Earnings AMKBY Earnings DSCSY Earnings SDVKY Earnings EPOKY Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles: Taiwan Semiconductor Soars on Earnings With More Room to RunBank of America Earnings Uncover Shifts in Consumer SpendingGoldman Sachs Earnings Reveal Market Moves Investors Can't IgnoreNike’s Post-Earnings Drop Presents a Buying OpportunityMicron Stock Soars as AI Demand Fuels Big Q4 Earnings BeatGameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth? This page (OTCMKTS:RCDTF) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDon’t Buy Another Stock Until Reading This…Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my up...Unstoppable Prosperity | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWar on Elon Escalates… Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adopti...Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica e Farmaceutica S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recordati Industria Chimica e Farmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCDTF Stock Alerts